TITLE

CC delivers Pharmacia IP victory in just nine months

AUTHOR(S)
Harris, Joanne
PUB. DATE
February 2005
SOURCE
Lawyer;2/28/2005, Vol. 19 Issue 8, p8
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
This article presents information related to Clifford Chance who has taken a pharmaceuticals patent case from its start to a Court of Appeal finish in just nine months. But Pharmacia Italia, which is a subsidiary of Pfizer, already owned the Great Britain patent Pharmorubicin. Mayne, represented by Taylor Wessing IP partner Simon Cohen. launched its court action. In the Mayne case, it was agreed that documentary disclosure would not be necessary, and the case was heard by Roger Wyand QC sitting as a deputy High Court judge.
ACCESSION #
16510506

 

Related Articles

  • Lemelson Foundation Dealt A Blow In Nevada Court. Andersen, Steven // Corporate Legal Times;Apr2004, Vol. 14 Issue 149, p22 

    Focuses on the ruling of the Nevada District Court for the intellectual property lawsuit filed by Symbol Technologies Inc. against the Lemelson Foundation. Overview of the practice of submarine patenting; Facts of the case; Contention of the court. INSET: Triple Whammy.

  • IMS INSIGHTS PATENT EXPIRATION.  // Medical Marketing & Media;Jul2005, Vol. 40 Issue 7, p8 

    Presents a graph on the sales of drugs in the U.S. losing patent protection.

  • Patent leathering. Jones, Stephen // Lawyer;1/17/2005, Vol. 19 Issue 2, p22 

    The article presents information on two cases related to patents in Great Britain. The leading opinion in each case was given by the redoubtable Lord Hoffmann, for many years our most senior judge, with vast experience in the patent field and the judge responsible for the Biogen decision. Lord...

  • Rambus Loses European Patent.  // Electronic News;2/16/2004, Vol. 50 Issue 7, pN.PAG 

    Reports on the invalidation of a patent of Rambus Inc. in Germany, France, Great Britain and Italy ruled by the Technical Board of Appeals of the European Patent Office. Coverage of the ruling; Companies that filed original opposition to the patent in 2000; Impact of the ruling on the shares of...

  • Supreme Court voids Pfizer patent for inadequate disclosure in cascading claims. Kondro, Wayne // CMAJ: Canadian Medical Association Journal;12/11/2012, Vol. 184 Issue 18, pE953 

    The article reports that the Supreme Court of Canada has voided Pfizer Canada Inc.'s patent for the impotence drug Viagra owing to company's failure for inadequate disclosure in cascading claims. It is expected that the Supreme Court ruling will allow generic drug manufacturers to create...

  • HOLMES v. VORNADO: A RADICAL CHANGE IN APPELLATE JURISDICTION. Etra, Joseph // Columbia Science & Technology Law Review;2008, Vol. 9, p1 

    In a recent decision, The Holmes Group, Inc. v. Vornado Air Circulation Systems, Inc., the United States Supreme Court altered the treatment of patent cases at the appellate level, and, in doing so, significantly limited Federal Circuit jurisdiction. Prior to this decision, the Court of Appeals...

  • COLLATERAL ESTOPPEL AND CLAIM CONSTRUCTION ORDERS: FINALITY PROBLEMS AND VACATUR SOLUTIONS. Garza, Anthony M. // Columbia Science & Technology Law Review;2008, Vol. 9, p1 

    Collateral estoppel could be a powerful tool in patent litigation. When a claim construction is necessary to a final judgment, ordinarily, an adverse party may not relitigate the construction in a future action. Current Federal Circuit jurisprudence, however, seems to offer an escape hatch....

  • International Intellectual Property. SIMBURG, MELVYN J.; ASTLE, MATTEW J.; BORNHAUSER, JONAS; BRUSHABER, SUSAN; FAHLBERG, ROBIN S.; FEIERABEND, STEPHEN W.; FREIHART, JESSICA; JONES, PAUL; KESTENS, CARL; STRINGFELLOW, JENNIFER LOVE; MARUGG, DANIEL; MCDONALD, BRUCE A.; MUNICOY, MARIANO; TAYLOR, DAVID; VOSS, W. GREGORY; WYNNE, MICHELLE // International Lawyer;Spring2012, Vol. 46 Issue 1, p215 

    The article presents information on the significant developments that took place in the international intellectual property law during 2011. Several trials based on patent, trademark and copyrights of different jurisdictions including Europe, China and the U.S. are discussed. The decisions made...

  • PATENTS.  // International Law Update;Aug2001, Vol. 7, p121 

    Reports on the international patent dispute involving therapeutic plant extract. Development of contract between Societe civile D'Investigations Pharmacologiques D'Aquitane of bordeaux, France (SCIPA) and Horphang Overseas Limited; Violation of Masquelier with French statute; Discussions on...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics